Evidence map›Paper›PMID 32349444›Full record

ArticleMolecules (Basel, Switzerland)2020

Genistin: A Novel Potent Anti-Adipogenic and Anti-Lipogenic Agent.

Yae Rim Choi, Jaewon Shim, Min Jung Kim

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Effects of Soybean Extracts Prepared with BionurukPreventive nutrition and food science · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Biosynthesis and Anticancer Activity of Genistein Glycoside Derivatives.Anti-cancer agents in medicinal chemistry · 2024
    Review
  15. Article
  16. Inhibitory Effects of Sesquiterpenoids Isolated fromInternational journal of molecular sciences · 2023
    Article
  17. Tanshinone-I for the treatment of uterine fibroids: Molecular docking, simulation, and density functional theory investigations.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yae Rim ChoiResearch Division of Food Functionality, Korea Food Research Institute, Wanju 55365, Korea.
Jaewon ShimResearch Division of Food Functionality, Korea Food Research Institute, Wanju 55365, Korea.
Min Jung KimResearch Division of Food Functionality, Korea Food Research Institute, Wanju 55365, Korea.
Korea Food Research Institute · KREwha Womans University · KR

Funding

Korea Institute of Planning and Evaluation for Technology in Food,Agriculture, Forestry and Fisheries(IPET) through High Value-added Food Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) 118035-3Main Research Program of the Korea Food Research Institute and 2017 Ottogi Foundation research program. E0164500-05
6 · The paper itself

Abstract

Soy isoflavones are popular ingredients with anti-adipogenic and anti-lipogenic properties. The anti-adipogenic and anti-lipogenic properties of genistein are well-known, but those of genistin and glycitein remain unknown, and those of daidzein are characterized by contrasting data. Therefore, the purpose of our study was to investigate the effects of daidzein, glycitein, genistein, and genistin on adipogenesis and lipogenesis in 3T3-L1 cells. Proliferation of 3T3-L1 preadipocytes was unaffected by genistin and glycitein, but it was affected by 50 and 100 µM genistein and 100 µM daidzein for 48 h. Among the four isoflavones, only 50 and 100 µM genistin and genistein markedly suppressed lipid accumulation during adipogenesis in 3T3-L1 cells through a similar signaling pathway in a dose-dependent manner. Genistin and genistein suppress adipocyte-specific proteins and genes, such as peroxisome proliferator-activated receptor γ (PPARγ), CCAAT-enhancer-binding protein α (C/EBPα), and adipocyte binding protein 2 (aP2)/fatty acid-binding protein 4 (FABP4), and lipogenic enzymes such as ATP citrate lyase (ACL), acetyl-CoA carboxylase 1 (ACC1), and fatty acid synthase (FAS). Both isoflavones also activate AMP-activated protein kinase α (AMPKα), an essential factor in adipocyte differentiation, and inhibited sterol regulatory element-binding transcription factor 1c (SREBP-1c). These results indicate that genistin is a potent anti-adipogenic and anti-lipogenic agent.

Indexed as

3T3-L1 CellsAcetyl-CoA CarboxylaseAdipocytesAdipogenesisAMP-Activated Protein KinasesAnimalsAnti-Obesity AgentsATP Citrate (pro-S)-LyaseCCAAT-Enhancer-Binding Protein-alphaCell SurvivalFatty Acid-Binding ProteinsFatty Acid SynthasesGene Expression RegulationGlycine maxIsoflavonesLipogenesisACC1 protein, mouseAcetyl-CoA CarboxylaseAMP-Activated Protein KinasesAnti-Obesity AgentsATP Citrate (pro-S)-LyaseCCAAT-Enhancer-Binding Protein-alphadaidzeinFabp4 protein, mouseFatty Acid-Binding ProteinsFatty Acid SynthasesgenistinglyciteinIsoflavonesPPAR gammaSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1anti-adipogenesisanti-lipogenesisgenistinsoy isoflavones

Identifiers

PMID32349444
PMCPMC7248826
OpenAlexW3018645024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.